Drawing for UVORA

USPTO serial 99580932

UVORA

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, CAMERON L
Law office
TMEG LAW OFFICE 106

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with UVORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ruochen Liu

2913 Via TorinoSanta Clara, CA 95051United States

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a dietary supplement for liver support; Dietary supplements for human consumption; Dietary supplements in the form of capsules; Nutritional supplements in the form of capsules; Dietary supplement beverage for promoting digestion; Dietary supplements also containing Milk thistle; Natural dietary supplements; Vitamin and mineral supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 12, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 12, 2026GNSLLETTER OF SUSPENSION E-MAILED—
May 12, 2026CNSLSUSPENSION LETTER WRITTEN—
May 6, 2026LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
May 5, 2026DOCKASSIGNED TO EXAMINER—
Apr 28, 2026LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Jan 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance